dual LAG-3 checkpoint inhibitor/IL-2 receptor beta/gamma agonist (Tentarix Biotherapeutics)

N/A

Report date: 2025/01/26 18:21:59

Base Information

Drug Namedual LAG-3 checkpoint inhibitor/IL-2 receptor beta/gamma agonist (Tentarix Biotherapeutics)

Drug Alias NameAnti-LAG3/Anti-IL-2R Beta/Gamma Bispecific Antibody (Tentarix Biotherapeutics)TNRX-257

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-2 receptor subunit gamma stimulantsInterleukin-2 receptor beta chain agonistsLymphocyte activation gene 3 protein inhibitors

TargetsInterleukin-2 receptor subunit gammaInterleukin-2 receptor beta chainLymphocyte activation gene 3 protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTentarix Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesTentarix Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A